This website uses cookies to enhance the user experience.
||
NERLIENS MESZANSKY AS

NERLIENS MESZANSKY AS914 553 695

Purchase and sale
Limited company
Økernveien 121 0579 OSLO, Norge

NERLIENS MESZANSKY AS

Kvalitetsutstyr til laboratoriet Nerliens Meszansky AS
NMAS (Nerliens Meszansky AS) er en av Norges største og ledende leverandører av laboratorieutstyr. Siden 1917 har vi levert instrumenter og forbruksvarer fra verdensledende produsenter til laboratorier innen helse, forskning og industri samt beredskap og forsvar. Vi har også en stor serviceavdeling og tilbyr lokal service i hele Norge på alle våre produkter.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Links

Organization

Chairman of the board
Years since formation
30 years
since Feb 19, 1995
Type
Limited company
VAT registered
Yes
Number of employees
54

Ownership

Number of shares and share classes
62,070
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
221,012,145
NOK
Annual total result 2024
9,732,446
NOK
Total equity 2024
29,387,530
NOK
Last update: Jul 30, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Chairman-
Board Member-
Alternate Member-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
Accountant-

Top 10 individual shareholders

NameRoleShares
-
1.53 %
indirectly
Last update: Aug 4, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
V
VIND INDUSTRY AS
Ordinary shares
62,070
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 0
    Operating profit 2024: NOK -452,000
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
221,012,145
223,055,640
255,260,345
450,469,902
Annual Total Result
9,732,446
5,742,717
8,675,543
85,989,271
Total assets
96,746,710
94,442,882
94,915,721
202,020,477
Total liabilities
67,359,179
59,109,612
56,615,461
166,047,301
Total equity
29,387,530
35,333,270
38,300,260
35,973,176

P&L

Year2024202320222021
Total operating income
221,012,145
223,055,640
255,260,345
450,469,902
Total operating costs
208,624,054
215,675,662
230,933,120
341,787,495
Operating result
12,388,091
7,379,977
24,327,225
108,682,407
Financial income/costs
-117,263
-142,006
-10,050,692
744,484
Profit before tax
12,270,828
7,237,971
14,276,534
109,426,891
Total tax & extraordinary income/cost
2,538,382
1,495,254
5,600,991
23,437,620
Annual Total Result
9,732,446
5,742,717
8,675,543
85,989,271

Balance overview

Year2024202320222021
Total fixed assets
15,807,453
17,235,319
13,517,340
24,837,067
Total current assets
80,939,257
77,207,563
81,398,381
177,183,410
Total assets
96,746,710
94,442,882
94,915,721
202,020,477
Short term debt
67,246,679
58,997,112
56,502,961
165,934,801
Long term debt
112,500
112,500
112,500
112,500
Total liabilities
67,359,179
59,109,612
56,615,461
166,047,301
Contributed capital
6,884,000
6,884,000
6,884,000
6,884,000
Retained earnings
22,503,530
28,449,270
31,416,260
29,089,176
Total equity
29,387,530
35,333,270
38,300,260
35,973,176
Total equity and liabilities
96,746,709
94,442,882
94,915,721
202,020,477

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods